Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osteotech: Bone Better Than Your Own

Executive Summary

Using a unique processing technology, Osteotech helped create a market for allograft tissue transplants by increasing availability and improving quality. Riding that technology, Osteotech has gone from providing services to developing products with a line of proprietary allograft tissue, expanding a market in which it remains the leader. While the tissue market is growing and attracting competition from large orthopedic companies, surgeons have been slow in coming around, concerned largely by safety issues similar to those facing blood products. And the specter of a biological solution hovers over the tissue transplant field. Yet, Osteotech remains confident it can continue to grow and fend off major competitors, while expanding internationally and adding spinal implants to the company's tissue products.
Advertisement

Related Content

SpineVision: Meeting the Competition Head On
SpineVision: Meeting the Competition Head On

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001012

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel